A Message From Ken Farber
Dear Friends,
I'm sure you agree—2020 was a year like no other.
Yet, despite the challenges presented by COVID-19, the Lupus...
Stories & News
Low-Dose Chemotherapy May Help Lupus Nephritis
February 22, 2021
In a recent study published in Arthritis & Rheumatology, LRA-funded researcher Dr. Xian Zhang found that a...
Join LRA’s Advocate for Lupus Research Week March 15 – 19, 2021
Your voices will be heard as loud and clear as ever, albeit virtually! Join us Monday, March 15 for our Advocate for Lupus...
Virtual Events Were Real-ly Successful!
While the pandemic made it impossible for the LRA to hold in person fundraising events, we still achieved great...
LRA Shares Tremendous Loss of Lupus Research Hero Dr. Marc Chevrier
February 10, 2021
The worldwide lupus community lost a brilliant researcher and a passionate champion with the recent passing of...
Putting Out the Fire – Celebrating A Lupus “Firefighter” During Black History Month
February 4, 2021
“Imagine that your house is on fire and someone inside started it - that’s lupus,” says Dr....
New CDC Study Estimates 204,295 Americans Have Lupus
January 29, 2021
According to a new analysis funded by the Centers for Disease Control and Prevention, about 204,295 Americans...
Update from LRA’s President on COVID-19 Vaccines in Lupus
January 14, 2020
Dear Friends,
Happy New Year! On behalf of all of us at the Lupus Research Alliance (LRA), thank...
Vaccines and Lupus: What to Know Amid COVID-19
January 14, 2021
LRA's President and CEO Kenneth Farber taped this video series - Vaccines and Lupus: What to Know...
Lupus Advocacy Delivers Again!
December 28, 2020
After much back and forth, last week the U.S. Congress passed the year-end spending deal, called the...
Existing Cancer Drug May Lower Inflammation in Autoimmune Diseases Like Lupus
December 14, 2020
In a recent study published in the Journal of Immunology, LRA-funded researcher Dr. John Zhang at Medical...
LRA-Supported Study Finds Similarities in the Immune Response Between Severe COVID-19 and Lupus Antiphospholipid Syndrome
December 2, 2020
The immune response during severe COVID-19 is similar to a lupus complication known as antiphospholipid syndrome, according...